Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CNTB Connect Biopharma > Main Composition
CNTB Connect Biopharma
0.7120.0000.00%
Post Mkt Price
0.7120.0000.00%
All
YOY
Do not show
Business

No Data

Region

No Data

Company Overview More
Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in Taicang, China.
CEO: Dr. Zheng Wei, PhD
Market: NASDAQ
Listing Date: 03/19/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist